T. Rowe Price Associates’s ZS PHARMA INC COMS TK (DE) ZSPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-1,006,253
Closed -$66.1M 2575
2015
Q3
$66.1M Sell
1,006,253
-348,305
-26% -$20.9M 0.01% 694
2015
Q2
$71M Sell
1,354,558
-6,020
-0.4% -$296K 0.01% 713
2015
Q1
$57.3M Buy
1,360,578
+691,407
+103% +$31.6M 0.01% 791
2014
Q4
$27.8M Buy
669,171
+277,371
+71% +$10.9M 0.01% 1035
2014
Q3
$15.4M Buy
+391,800
New +$12.9M ﹤0.01% 1186

T. Rowe Price Associates's ZSPH Position: Q4 2015 in Review

T. Rowe Price Associates sold out of ZS PHARMA INC COMS TK (DE) (ZSPH) in Q4 2015, closing a stake of 1,006,253 shares — an estimated $66.1M sold.

T. Rowe Price Associates first reported a position in ZSPH in Q3 2014 and held it in 5 quarters. The position peaked at $71M in Q2 2015. 0 funds tracked by Wall St. Rank hold ZSPH as of Q4 2015.

  • T. Rowe Price Associates reported no remaining ZS PHARMA INC COMS TK (DE) position as of Q4 2015 after selling out during the quarter.
  • T. Rowe Price Associates sold 1,006,253 ZS PHARMA INC COMS TK (DE) shares in Q4 2015, an estimated $66.1M.
  • T. Rowe Price Associates first reported a position in ZS PHARMA INC COMS TK (DE) in Q3 2014 and held it in 5 quarters.
  • T. Rowe Price Associates's ZS PHARMA INC COMS TK (DE) position peaked at $71M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held ZS PHARMA INC COMS TK (DE) as of Q4 2015.

Based on T. Rowe Price Associates's 13F filing for Q4 2015, filed 16 Feb 2016.